吸烟是全球卒中负担的主要危险因素。我们以前曾报道,与当前吸烟相关的全球人群卒中归因风险(PAR)为12.4%。在这项研究中,我们旨在探讨当前烟草使用与不同类型烟草暴露和环境烟草烟雾(ETS)暴露对中风和中风亚型风险的关联。以及地区和国家收入水平。
INTERSTROKE研究是一项急性首次卒中的病例对照研究,于2007年1月11日至2015年8月8日在全球32个国家招募了13,462例卒中病例和13,488例对照。烟草使用风险和ETS暴露与整体中风的关系进行了分析,缺血性和脑出血(ICH),和TOAST病因中风亚型(大血管,小船,心脏栓塞,和未确定)。
■当前吸烟与所有卒中风险增加相关(比值比[OR]1.64,95%CI1.46-1.84),并且与缺血性卒中(OR1.85,95%CI1.61-2.11)的相关性强于ICH(OR1.1995%CI1.00-1.41)。当前吸烟者中风的OR和PAR在地区和收入水平之间差异显着,高收入国家(HIC)的几率最高(OR3.0295%CI2.24-4.10)和PAR(18.6%,15.1-22.8%)。在缺血性卒中的病因亚型中,目前吸烟的相关性最强的是大血管卒中(OR2.16,95%CI1.63-2.87)和原因不明(OR1.97,95%CI1.55-2.50).过滤(OR1.73,95%CI1.50-1.99)和非过滤(OR2.59,95%CI1.79-3.77)香烟均与中风风险相关。ETS暴露以剂量依赖的方式增加中风的风险,每周暴露超过10小时会增加所有卒中的风险(OR1.95,95%CI1.69-2.27),缺血性卒中(OR1.89,95%CI1.59-2.24)和ICH(OR2.00,95%CI1.60-2.50)。
■根据使用的烟草类型,中风的风险大小和PAR存在显着差异,活跃和ETS暴露,和不同收入水平的国家。应实施阻止任何形式的烟草使用和建立无烟环境的具体战略,以减轻中风的全球负担。
■加拿大卫生研究院,加拿大心脏和中风基金会,加拿大卒中网络,瑞典研究委员会,瑞典心肺基金会,区域执行委员会卫生和医疗委员会,VästraGötaland区,通过几家制药公司的无限制资助,AstraZeneca的主要捐款,勃林格勃·英格尔海姆(加拿大)辉瑞(加拿大)梅尔克,夏普和多姆,瑞典心肺基金会,英国宝箱,英国心脏和中风。
UNASSIGNED: Smoking is a major risk factor for the global burden of stroke. We have previously reported a global population attributable risk (PAR) of stroke of 12.4% associated with current smoking. In this study we aimed to explore the association of current tobacco use with different types of tobacco exposure and environmental tobacco smoke (ETS) exposure on the risk of stroke and stroke subtypes, and by regions and country income levels.
UNASSIGNED: The INTERSTROKE study is a
case-control study of acute first stroke and was undertaken with 13,462 stroke cases and 13,488 controls recruited between January 11, 2007 and August 8, 2015 in 32 countries worldwide. Association of risk of tobacco use and ETS exposure were analysed with overall stroke, ischemic and intracerebral hemorrhage (ICH), and with TOAST etiological stroke subtypes (large vessel, small vessel, cardioembolism, and undetermined).
UNASSIGNED: Current smoking was associated with an increased risk of all stroke (odds ratio [OR] 1.64, 95% CI 1.46-1.84), and had a stronger association with ischemic stroke (OR 1.85, 95% CI 1.61-2.11) than ICH (OR 1.19 95% CI 1.00-1.41). The OR and PAR of stroke among current smokers varied significantly between regions and income levels with high income countries (HIC) having the highest odds (OR 3.02 95% CI 2.24-4.10) and PAR (18.6%, 15.1-22.8%). Among etiological subtypes of ischemic stroke, the strongest association of current smoking was seen for large vessel stroke (OR 2.16, 95% CI 1.63-2.87) and undetermined cause (OR 1.97, 95% CI 1.55-2.50). Both filtered (OR 1.73, 95% CI 1.50-1.99) and non-filtered (OR 2.59, 95% CI 1.79-3.77) cigarettes were associated with stroke risk. ETS exposure increased the risk of stroke in a dose-dependent manner, exposure for more than 10 h per week increased risk for all stroke (OR 1.95, 95% CI 1.69-2.27), ischemic stroke (OR 1.89, 95% CI 1.59-2.24) and ICH (OR 2.00, 95% CI 1.60-2.50).
UNASSIGNED: There are significant variations in the magnitude of risk and PAR of stroke according to the types of tobacco used, active and ETS exposure, and countries with different income levels. Specific strategies to discourage tobacco use by any form and to build a smoke free environment should be implemented to ease the global burden of stroke.
UNASSIGNED: The Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Swedish Research Council, Swedish Heart and Lung Foundation, The Health & Medical Care Committee of the Regional Executive Board, Region Västra Götaland, and through unrestricted grants from several pharmaceutical companies with major contributions from Astra Zeneca, Boehringer Ingelheim (Canada), Pfizer (Canada), MERCK, Sharp and Dohme, Swedish Heart and Lung Foundation, UK Chest, and UK Heart and Stroke.